Optimizing Antiviral Outcomes Through Clinical Pharmacology
Overview Assessment of Needs Several new antiviral drugs have become available in recent years including therapies for SARS-CoV2 and long-acting agents for HIV prevention and treatment. This webinar will compare and contrast the clinical pharmacology and concentration-effect associations for contemporary antivirals. Modern analytical approaches to define antiviral pharmacokinetic-dynamic relationships will also be discussed. Learning (more…)
Implementation of Long-Acting PrEP: Case-Based Panel Discussion With Clinicians
Overview Assessment of Needs This case-based panel webinar will discuss the most challenging issues in drug therapy and anticipated barriers to the implementation of long-acting injectable preexposure prophylaxis (PrEP), which was approved by the US Food and Drug Administration in December 2021. This webinar will review key aspects of its clinical pharmacology and the (more…)
Detailed Discussion on the Latest Issues in COVID-19 Rebound, Omicron Subvariants BA.4 and BA.5, Current and Next Generation COVID-19 Vaccines, Pediatric Vaccine Rollout, Monkeypox, and More
Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. This Dialogue will provide a robust and relevant discussion of COVID-19 and SARS-CoV-2 at the time. Note, Dialogues (more…)
Unique Issues in People With HIV and Hepatitis B/D Coinfections
Overview Assessment of Needs Liver disease is currently one of the leading causes of morbidity and mortality in people with HIV. This webinar will review the latest treatment strategies for hepatitis B/D coinfections in people with HIV, including patient selection, medication use, and monitoring. New therapies in development will also be discussed. Learning Objectives (more…)
COVID-19 Prevention and Management: HIV Coinfection, Outpatient Management, Hospitalization, and Post-COVID-19 Complications
Last Modified: Program Description This course will be a half-day virtual update covering the latest clinical updates on COVID-19. This course will include an overview of the clinical relationship between HIV and COVID-19, 2 case-based panel discussions on difficult cases in prevention, outpatient care, and inpatient (more…)
Key Antiretroviral Drug-Drug Interactions With Mycobacterium tuberculosis Infection in Persons With HIV: A Case-Based Presentation
Overview Assessment of Needs Tuberculosis (TB) is a preventable but leading cause of death in persons with HIV (PWH). Mycobacterium avium complex (MAC) typically occurs when the CD4+ count is less than 50 cells/μL. This case-based presentation will review the key antiretroviral considerations and drug-drug interactions associated with the management of TB and MAC (more…)
Simplifying Treatment of Hepatitis C and Overcoming Barriers to Cure
Overview Assessment of Needs Eliminating hepatitis C will require major efforts to prevent new infections and the simplification of current hepatitis C management approaches will be crucial. This webinar will highlight the simplified approaches for diagnosing and treating hepatitis C, including for people with HIV, and the potential to expand treatment. Additionally, it will (more…)
Latest Update on Urgent Virus Outbreaks: COVID-19, Monkeypox, and the Resurgence of Vaccine-Preventable Diseases
Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us (more…)
What You Need to Know About the Diagnosis and Treatment of Human Monkeypox Virus
Overview Assessment of Needs This webinar will provide an update on what clinicians need to know regarding monkeypox, particularly the latest guidance in clinical recognition, management, and treatment. This webinar is part 1 of our 2-part Monkeypox Webinar Series. Part 2 will discuss the Epidemiology and Public Health Response to the Monkeypox Outbreak. Learning (more…)
Epidemiology and Public Health Response to the Monkeypox Outbreak
Overview Assessment of Needs This webinar will provide a historical overview of monkeypox before 2022 and how the outbreak has reemerged globally and in the United States. This webinar will focus on the overall public health response in the United States, particularly around testing, contact tracing, prevention, vaccination, and future scenarios, including its gaps. (more…)